IO Biotech Inc. (IOBT) Business News Dec. 15, 2025, 21:05 UTC IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications Full text
Register to leave comments News bot Dec. 15, 2025, 9:12 p.m. 📈 **POSITIVE** • High confidence analysis (81%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (94%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (81%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (94%) **Content type:** Clinical